The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.
Identifieur interne : 000C61 ( PubMed/Checkpoint ); précédent : 000C60; suivant : 000C62The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.
Auteurs : Naadira Vanker [Afrique du Sud] ; Hayley IppSource :
- South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde [ 0256-9574 ] ; 2013.
Descripteurs français
- KwdFr :
- MESH :
- analyse : Antigènes CD38.
- immunologie : Infections à VIH, Lymphocytes T CD8+.
- Adulte, Cytométrie en flux, Femelle, Humains, Mâle, Numération des leucocytes, Numération des lymphocytes CD4, Études transversales.
English descriptors
- KwdEn :
- MESH :
- chemical , analysis : Antigens, CD38.
- immunology : CD8-Positive T-Lymphocytes, HIV Infections.
- Adult, CD4 Lymphocyte Count, Cross-Sectional Studies, Female, Flow Cytometry, Humans, Leukocyte Count, Male.
Abstract
A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.
PubMed: 24388088
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:24388088Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</title>
<author><name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:24388088</idno>
<idno type="pmid">24388088</idno>
<idno type="wicri:Area/PubMed/Corpus">001595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001595</idno>
<idno type="wicri:Area/PubMed/Curation">001595</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001595</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001595</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001595</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</title>
<author><name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</nlm:affiliation>
<country xml:lang="fr">Afrique du Sud</country>
<wicri:regionArea>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town</wicri:regionArea>
<wicri:noRegion>Cape Town</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</author>
</analytic>
<series><title level="j">South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</title>
<idno type="ISSN">0256-9574</idno>
<imprint><date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Antigens, CD38 (analysis)</term>
<term>CD4 Lymphocyte Count</term>
<term>CD8-Positive T-Lymphocytes (immunology)</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>HIV Infections (immunology)</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Antigènes CD38 (analyse)</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Infections à VIH (immunologie)</term>
<term>Lymphocytes T CD8+ (immunologie)</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Numération des lymphocytes CD4</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antigens, CD38</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Antigènes CD38</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à VIH</term>
<term>Lymphocytes T CD8+</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>CD8-Positive T-Lymphocytes</term>
<term>HIV Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>CD4 Lymphocyte Count</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Flow Cytometry</term>
<term>Humans</term>
<term>Leukocyte Count</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Cytométrie en flux</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Numération des leucocytes</term>
<term>Numération des lymphocytes CD4</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24388088</PMID>
<DateCreated><Year>2014</Year>
<Month>01</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>03</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>09</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">0256-9574</ISSN>
<JournalIssue CitedMedium="Print"><Volume>104</Volume>
<Issue>1</Issue>
<PubDate><Year>2013</Year>
<Month>Oct</Month>
<Day>11</Day>
</PubDate>
</JournalIssue>
<Title>South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde</Title>
<ISOAbbreviation>S. Afr. Med. J.</ISOAbbreviation>
</Journal>
<ArticleTitle>The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection.</ArticleTitle>
<Pagination><MedlinePgn>45-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.7196/samj.6983</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A feature of HIV/AIDS is chronic immune activation, which results in a number of complications including inflammation-related disorders and blood cytopaenias. Immune activation status is not routinely tested in HIV infection. However, the full blood count (FBC) is a commonly performed test.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We hypothesised that FBC parameters would be significantly different in HIV-infected v. -uninfected individuals, and that some of these parameters would correlate with markers of immune activation (i.e. percentage CD38 expression on CD8(+) T cells (%CD38onCD8)) and disease progression (i.e. CD4(+) counts) in HIV infection.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">This was a cross-sectional study with 83 HIV-infected adults who were antiretroviral therapy-naive and clinically well, and 51 HIV-uninfected adults. The %CD38onCD8 and CD4(+) counts were determined by flow cytometry and the FBC was performed on a Siemens ADVIA 2120 system. FBC parameters investigated were total white cell count (WCC), haemoglobin (Hb) concentration, platelet count, absolute neutrophil count, absolute lymphocyte count, and percentage of large unstained cells (%LUCs).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Significant differences were found between the HIV-infected and -uninfected groups for total WCC, Hb, neutrophil count, lymphocyte count and %LUCs. The mean ± standard deviation (SD) for the total WCC (5.3±1.3 v. 6.9±2.2; p≤0.001) and the %LUCs (2.5±0.9 v. 2.0±0.9; p=0.001) both showed correlations with CD4(+) counts and %CD38onCD8.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The total WCC and %LUCs showed significant differences in HIV-infected individuals and correlated with markers of immune activation and disease progression. This suggests the potential use of these parameters as markers of immune activation in HIV infection.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vanker</LastName>
<ForeName>Naadira</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Division of Haematopathology, National Health Laboratory Service and Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa. naadira.vanker@nhls.ac.za.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ipp</LastName>
<ForeName>Hayley</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2013</Year>
<Month>10</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>South Africa</Country>
<MedlineTA>S Afr Med J</MedlineTA>
<NlmUniqueID>0404520</NlmUniqueID>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>EC 3.2.2.5</RegistryNumber>
<NameOfSubstance UI="D051997">Antigens, CD38</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051997" MajorTopicYN="N">Antigens, CD38</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018414" MajorTopicYN="N">CD8-Positive T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007958" MajorTopicYN="Y">Leukocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2013</Year>
<Month>06</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24388088</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Afrique du Sud</li>
</country>
</list>
<tree><noCountry><name sortKey="Ipp, Hayley" sort="Ipp, Hayley" uniqKey="Ipp H" first="Hayley" last="Ipp">Hayley Ipp</name>
</noCountry>
<country name="Afrique du Sud"><noRegion><name sortKey="Vanker, Naadira" sort="Vanker, Naadira" uniqKey="Vanker N" first="Naadira" last="Vanker">Naadira Vanker</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C61 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000C61 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaSubSaharaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:24388088 |texte= The use of the full blood count and differential parameters to assess immune activation levels in asymptomatic, untreated HIV infection. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:24388088" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SidaSubSaharaV1
This area was generated with Dilib version V0.6.32. |